EDITORIAL ANNOTATIONS

RECENT ADVANCES IN THE USE OF IdTHIUM
The four major recent advances have been ( I ) the substantiation by Baastrup and Schou of their original claim (Baastrup and Schou, 1967) three years ago that maintenance lithium medication was significantly effective in preventing recurrent depressive as well as manic episodes, (2) the preliminary studies by Serry (1969) on the use of a lithium excretion test to identify probable lithium responders, (3) an increasing awareness that lithium is sometimes dramatically successful as "end of the road" medication in occasional so-called chronic schizophrenics, especially in those patients who have at some time exhibited manic features, and (4) equally necessary as adjuvant treatment in a significant proportion of young cyclothymes who are initially diagnosed as sociopaths or as suffering from a behaviour disorder.
Baastrup and Schou's first paper was criticized very strenuously by Blackwell and Shepherd (1968) on methodological grounds, and as a result their claim that lithium was prophylactic against recurrent depression has up till now been received with considerable scepticism. As they themselves had long been convinced on clinical grounds of the validity of their claims, they had strong ethical objections to discontinuing maintenance lithium medication in any of their patients. It was only after considerable hesitation that they finally decided to embark on a methodologically impeccable double-blind discontinuation study in two groups of patients, manicdepressives (bipolar type) and recurrent endogenous depressives (Baastrup ct ol., 1970) . Of the 91 patients who fulfilled their selection criteria, there were 7 "drop-outs" for various reasons, leaving 84 to commence the trial. In 38 pairs, both partners completed the trial and only these pairs were used for the sequential analysis. The trial concluded when the level of significance was reached, and in fact it only took five months. In the manic-depressive group, there were 12 relapses and amongst the recurrent depressives there were 9. All relapses occurred in the placebo patients, none amongst those who had remained on lithium medication. The investigators' only fear is that the results might be thought too good to be true! Baastrup and Schou achieve better results with lithium than we do in Australia, largely because we tend to be too conservative and less systematic. They are prepared to give if necessary up to double our usual maximum dose, i.e., up to 3,600 mg. daily of lithium carbonate, but it must be emphasized that they control dosage in the light of regular, and, in the early stages, frequent serum lithium measurements. It is important that the blood sample be taken not less than 12 hours after the last dose, i.e., when the post-ingestion peak has passed and a base level has been reached. A dose response curve illus-trates the fact that under a base reading of 0.4 niEq,'I there is negligible prophyhctic effect, but above this the proportion of satisfactory results rises rapidly up to 1 .O mEql1. The dosage schedule is aimed a t maintaining ;I basal blood level somewhere about 0.8 niEql I , but clinical response is the paramount guide line.
When the Danish studies mentioned above become more widely known, there is no doubt that there will be an immediate and increasingly effective use of lithium in recurrent cndogenous depression. Schou is careful to point out that, although lithium is almost immediately prophylactic in preventing manic relapses, it may take up to a year of maintenance medication before depressive relapses are completely abolished. In what might be called that probationary year. depression may still occur, but increasingly mildly. Patients should be briefed ;IS to what to expect.
In Cade's original paper (Cade, 1949) , the results of the treatment of s i x schizophrenic patients were reported. It was noted at the time that, although there was no fundamental improvement in any of them, the three who were usually restless, noisy and abusive lost their excitement and restlessness and became quiet and amenable for the first time in years.
The taking of a nocturnal hypnotic had been a routine and could be discontinued during treatment. They reverted to their previous state upon cessation of medication. The response of one patient who these days would be described as a schizo-affective was also reported. The manic features remitted entirely but the schizophrenic symptoms remained. These observations have been repeated and confirmed many times since. It begins to appear that the therapeutic value of lithium in the treatment of some schizophrenics has been underestimated. The present writer reported two successful cases in discussing this point several years ago (Cade, 1969) , and suggested that all otherwise therapeutically recalcitrant chronic schizophrenics who have exhibited manic features at one time or another should be given a therapeutic trial with lithium. There will be some who will respond most dramatically. Forssman and Walinder in 1969 documented a series of 27 patients with atypical psychoses whom they treated with lithium. In 9. there was no effect whatever. In the remaining 18, they observed what they considered to be distinct improvement, sometimes modest, sometimes very striking. They observed that in those patients who were favourably influenced a periodical course was a frequent finding.
Because lithium can at times be so gratifyingly and dramatically effective in the treatment of atypical, i.e., apparently non-manic psychotic states, it has become increasingly urgent to be able to identify those who are likely to respond. As indicated earlier, the clinical history may provide some pointers or the therapeutic trial itself may always be instituted. However, a n objective and reliable test would be the ideal. This is why Serry's recently published preliminary findings in identifying lithium responders on the basis of a lithium excretion test is so important (Serry, 1969) . As the paper was published in this Jortrriul not long ago, it will be reviewed only briefly. In short, Serry claims that, on the basis of the results after a test dose of 1,200 mg. of lithium carbonate and estimation of the amount excreted in a fourhour specimen of urine, patients can be divided into relative retainers and relative excreters. Retainers prove to be responders and excreters to be nonresponders. This is certainly true in the case of manics. It is now established that about 75 per cent of typical manics respond very satisfactorily to lithium. It is this group that prove to be retainers, and the quarter or so who d o not respond can be shown to be excreters. It is quite impossible to differentiate the responders and the non-responders o n clinical grounds. Perhaps one o f the most important findings that Serry m:idr was the fact that such n large proportion (40 per cent in his small series) of young so-called sociopaths are in fact cyclothymes, that to a very large extent their sociopathy is merely a symptom of their cyclothymia, that they are lithium retainers, and that lithium is an essential therapeutic weapon in their total management. Parkville. 4i ;. 3052.
BIOGENIC AMINEX AND PSYCHIATRY
In 1937, Papez proposed a "mechanism of emotion" which involved recruiting pathways through the hippocampus, fornix, mammillary bodies, bundle of Vicq d'Azyr, thalamus, cingulates and amygdalae, i.e., the rhinencephalon. This anatomical circuit has now been described in greater detail, and the theory of Papez elaborated and confirmed.
The rhinenccphalon, together with the hypothalamus and the midbrain, are the chief repositories of the biogenic amines, viz., acetyl choline, the indoleamines (chiefly serotonin) and the catecholamines (chiefly noradrenaline and doparnine) (Figure 1) .
The role of two of these, the monoamines, i.e., the indoleamines and the catecholamines, will bc eonsidered with reference to their possible function in the pathogenesis of psychiatric disorders. Serotonin is found particularly in the limbic structures, i.e., the rhinencephalon; dopamine in the extrapyramidal system; and noradrenaline in central autonomic and alerting systems. In these sites, it has been suggested that each may function as a synaptic transmitter or as a modulator of neuronal activity in functionally distinct systems of the brain.
Physiological Functions
( i ) Both catecholamines and indoleamines are important for the rcgulation of normal sleep; the alerting effect and insomnia associated with the use of M A 0 1 drugs is well known.
Jouvet (1968) stressed the importance of serotonin in the control of normal sleep. Tsuchiya el ( I / . (1969) found that total sleep deprivation led to a slight increase in acetylcholine in the telencephalon, and the levels of serotonin and noradrenaline showed a transient but marked decrease. Oswald (1965) has shown that tryptophan, a precursor of serotonin, given orally before retiring will cause an abnormally early onset of paradoxical sleep. Methysergide, a serotonin blocking agent, will prevent this response. Parachlorophenylalanine, which prevents the synthesis of serotonin, is associated with sleep deprivation states in some species.
The sleep disturbances associated with many psychiatric disturbances may then be related to alterations in the brain levels of the biogenic amines, particularly of serotonin. Indeed, sleep disturbance may be one of the earliest and most dramatic symptoms of a severe depressive illness. In addition, hyperarousal states and suppression of deep sleep have also been described in the schizophrenias.
(ii) Marley el a/. (1968) suggested that serotonin might have a role in temperature regulation. Lomax er a/. (1969) argued that the catecholamines and acetyl choline are also important. Diurnal variation of temperature may be correlated with changes in levels of the biogenic amines, ACTH, steroid and melatonin levels, all of which show circadian rhythms. The biogenic amines may therefore also be associated with the regulation of the "biological clocks" (Quay, 1968; Dixit and Buckley, 1967) .
(iii) Smythies (1965) argued that the biogenic amines combined as co-modulators of normal movement. The maintenance of normal tone follows a balance between acetylcholine and dopamine in the striatal complex. Tremor seems to follow an imbalance between serotonin, noradrenaline and histamine.
